Vivos Therapeutics Inc. logo

Vivos Therapeutics Inc.

VVOS | NASDAQ
Chart Builder DCF Calculator
$0.50
-$0.01 (-2.19%)
Jun 18, 2026, 4:00 PM ET · Market open

Company Profile

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.

Key Executives

Name Position
Jennifer Hauser Executive Assistant to CEO and Chairman & CFO
R. Kirk Huntsman Co-Founder, Chairman of the Board & Chief Executive Officer
Bradford K. Amman Chief Financial Officer, Treasurer & Secretary
John Ballard Senior Vice President of Technology
Michael E. Bruhn Executive Vice President of Business Operations Integration
Nicholas DeGennaro Senior Vice President of Mergers and Acquisition Group
RaeAnn Byrnes Co-Founder and Senior Vice President of Events & Clinical Advisory Services
Ruth Hembree Senior Vice President of Practice Services
Susan McCullough Co-Founder & Executive Vice President of Operations
Terry Jones Senior Vice President of Human Resources
Todd Huntsman Co-Founder & Senior Vice President of Product and Technology

Latest SEC Filings

Date Type Title
May 20, 2026 10-Q Quarterly Report
May 15, 2026 NT 10-Q Filing
May 15, 2026 SC 13G Statement of acquisition of beneficial ownership b...
May 08, 2026 EFFECT Filing
May 08, 2026 424B3 Filing
Apr 30, 2026 S-3/A [Amend] Filing
Apr 22, 2026 8-K Current Report
Apr 15, 2026 8-K Current Report
Apr 15, 2026 10-K Annual Report
Apr 10, 2026 3 Filing
View All SEC Filings
Vivos Therapeutics Inc.
Vivos Therapeutics Inc. logo
Country United States
IPO Date Dec 10, 2020
Industry Medical - Devices
Sector Healthcare
Employees 109
CEO R. Kirk Huntsman

Contact Details

9137 Ridgeline Boulevard Highlands Ranch, Colorado 80129 United States

Stock Details

Ticker Symbol VVOS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001716166
CUSIP Number 92859E108
ISIN Number US92859E2072
SIC Code 3841

© 2026 bestshares.com. All rights reserved.